OTC liver protectives sales grow 36% in first quarter

Published: 2011-06-10 06:57:00

Updated: 2011-06-10 06:57:00

Sales of OTC liver protective in domestic market jumped 36 percent, to 21.5 billion won, in the first half this year compared with the same period from a year earlier, thanks much to companies’ effective advertisement campaign, according to market sources.

The leading brand “Ursa” of Daewoong ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK